Nomifensine

This classification denotes an antidepressant agent with the molecular formula C16H18N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1LGS5JRP31, chemically known as 1,2,3,4-tetrahydro-2-methyl-4-phenyl-8-isoquino* but generally known as nomifensine, which bears US NIH Compound Identifier 4528. European Medicines Agency schedules Nomifensine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09347MIG. The term NOMIFENSINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules nomifensine in its Anatomical Therapeutic Chemical (ATC) Classification. NOMIFENSINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nomifensine under HS 29334990 and SITC 51575. As of Q4 2014, NOMIFENSINE remains the US FDA Preferred Term for this commodity. Nomifensine bears US NLM identifiers UMLS ID C0028277 and NCI Concept Code C72824. SMILES: N1(CC(c2c(C1)c(N)ccc2)c1ccccc1)C.